Eagle Pharmaceuticals, Inc. Interest Expense, Other
Eagle Pharmaceuticals, Inc. reported Interest Expense, Other of $527.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2017-11-08
- Eagle Pharmaceuticals, Inc. interest expense, other for the quarter ending 2017-09-30 was $527.00K, a 17466.67% increase year-over-year.
- Eagle Pharmaceuticals, Inc. interest expense, other for the quarter ending 2017-06-30 was $40.00K, a 1233.33% increase year-over-year.
- Eagle Pharmaceuticals, Inc. interest expense, other for the quarter ending 2017-03-31 was $27.00K, a 2600.00% increase year-over-year.
- Eagle Pharmaceuticals, Inc. interest expense, other for the quarter ending 2016-09-30 was $3.00K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month |
|---|---|---|---|
| 2017-09-30 | $527.00K 10-Q · filed 2017-11-08 | $567.00K derived: sum of 2 quarters · filed 2017-11-08 | $594.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $40.00K 10-Q · filed 2017-08-09 | $67.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $27.00K 10-Q · filed 2017-05-08 | ||
| 2016-09-30 | $3.00K 10-Q · filed 2017-11-08 | $6.00K derived: sum of 2 quarters · filed 2017-11-08 | $6.00K 10-Q · filed 2017-11-08 |
| 2016-06-30 | $3.00K 10-Q · filed 2017-08-09 | $4.00K 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $1.00K 10-Q · filed 2017-05-08 |